We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House Committee on Energy and Commerce voted Thursday in favor of amending the FAIR Drug Pricing Act of 2019, a bill that would require drug manufacturers to justify price increases to HHS. Read More
The FDA issued a draft guidance for trials of hormonal birth control products that makes recommendations regarding enrollment criteria, study elements, and safety and efficacy considerations. Read More
The FDA issued draft recommendations for drug developers on how to make the best use of the agency’s online database of inactive ingredients. Read More